Pelvic Organ Prolapse (POP) Terminated Phase 4 Trials for Solifenacin (DB01591)

Also known as: Pelvic Organ Prolapse

IndicationStatusPhase
DBCOND0052791 (Pelvic Organ Prolapse (POP))Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01092624Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal ProlapseTreatment